top of page
amarin
amylyx
argenx
astellas
Bayer
Takeda
Sobi
Bluebird Bio
camurus
deciphera
Dr Falk Pharma
GALDERMA
Takeda
Sobi
Lupin
Mereo BioPharma
Menarini Stemline
MIRUM
norgine
Takeda
Sobi
pharmanovia
pharma &
recordati
Seagen
seadana
Takeda
Sobi
Vertex
Viatris
recordati
Seagen
seadana
Takeda
Sobi
amarin
argenx
amylyx
astellas
bluebird bio
camurus
Bayer-Logo
BioCryst
BioMarin
GALDERMA
Dr Falk Pharma
deciphera
lupin-logo
Eli_Lilly
Incyte
norgine
orphalan
Pfizer
pharmanovia
pharma &
Vertex
Viatris
recordati
Seagen
seadana
Sobi
Takeda
amarin
amylyx
argenx
astellas
Bayer
BioCryst
BioMarin
bluebird bio
camurus
deciphera
Dr Falk
GALDERMA
Incyte
Eli_Lilly
lupin
Mereo
Menarini Stemline
MIRUM
norgine
orphalan
Pfizer
pharmanovia
pharma &
recordati
Seagen
seadana
Sobi
Takeda
Vertex
Viatris
recordati
Seagen
seadana
Sobi
Takeda
AdobeStock_303132792.jpeg

Building Connection
and Trust

Fostering collaboration across patients, caregivers, and payers to accelerate access to care.

Support Programs

Patient-Centric Solutions

for Better outcomes

hover image
AdobeStock_508089682.jpeg

Our Mission

How We Support Patient Access

01

Our Purpose

Bringing innovative medicines of pharmaceutical and biotech companies to patients, sustainably and meaningfully

03

Our Approach

​Strategic engagement and executional excellence with deep respect for the patient’s voice.

Guided Patient Access

We deliver strategic, landscape-driven access planning that minimises delays and rejections, facilitates early stakeholder dialogue, and embeds patient priorities at the core of your access strategy.

more

Real World Data

We design and implement Belgium-specific real-world evidence pilots, identifying the right registries and clinical partners while integrating meaningful patient-reported outcomes to strengthen your value proposition.

more

Pricing & Reimbursement

We build localised value stories, providing end-to-end support from early access to reimbursement.

more
Axes Health Team

The Axes Health team 

Dedicated to Patient Access

Pricing and reimbursement are complex

We Help You navigate

Leveraging deep insights into local healthcare systems, we develop robust pricing and reimbursement strategies.

Cardiology

Nephrology

Haematology

Oncology

Respiratory

Neurology

Orphan Diseases

Dermatology

Therapeutic Domains

We  bring extensive experience across a broad range of therapeutic domains

Value Proposition

Crafting a compelling value story and gathering necessary clinical and economic evidence.

02

Landscape Assessment

An in-depth analysis of the current landscape, unmet needs, and payer perceptions.

01

Strategy Development

Defining the optimal pricing, contracting, and access strategy for each target market.

03

04

Execution & Launch

Following up on addressing clinical and budgetary uncertainties to maintain patient access.

Integrated Market Access Solutions

A systematic approach ensuring no critical milestone is overlooked, from early-stage development to post-launch optimisation.

Our Methodology

Why Choose Axes Health? 

Recognised executional excellence.

Deep respect for the patient's voice

Unmatched expertise in rare diseases.

Respected partner by health authorities.

ABOUT US

SERVICES

HOME

bottom of page